Literature DB >> 28976499

Prostate cancer: Foxy-5 in prostate cancer model.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28976499     DOI： 10.1038/nrurol.2017.160

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.

Authors:  Giacomo Canesin; Susan Evans-Axelsson; Rebecka Hellsten; Agnieszka Krzyzanowska; Chandra P Prasad; Anders Bjartell; Tommy Andersson
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240
  1 in total
  3 in total

Review 1.  Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.

Authors:  Yundong He; Weidong Xu; Yu-Tian Xiao; Haojie Huang; Di Gu; Shancheng Ren
Journal:  Signal Transduct Target Ther       Date:  2022-06-24

Review 2.  Role of prostate cancer stem-like cells in the development of antiandrogen resistance.

Authors:  Prem Prakash Kushwaha; Shiv Verma; Shashank Kumar; Sanjay Gupta
Journal:  Cancer Drug Resist       Date:  2022-06-01

Review 3.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.